PSYB.H — Psybio Therapeutics Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
Annual cashflow statement for Psybio Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
R2018 June 30th | 2019 June 30th | 2020 June 30th | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | fx Final | fx Final | fx Final | Final | Final |
| Net Income/Starting Line | -0.041 | -0.021 | -0.016 | -11 | -4.89 |
| Depreciation | |||||
| Non-Cash Items | 0.007 | 0 | 0.023 | 3.37 | 0.7 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.007 | 0.007 | -0.031 | 0.694 | 0.597 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -0.041 | -0.014 | -0.024 | -6.95 | -3.44 |
| Other Investing Cash Flow Items | — | — | — | -3.56 | 3.52 |
| Sale of Business | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | — | — | — | -3.56 | 3.52 |
| Financing Cash Flow Items | -0.009 | 0 | — | -0.908 | 0 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -0.006 | 0 | — | 10.4 | -0.055 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.046 | -0.014 | -0.024 | -0.145 | 0.033 |